Brainomix

Executives conferring
By  Anthony Vecchione 02:29 pm March 20, 2025
Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round. The round was co-led by existing investors Parkwalk Advisors and the Boehringer Ingelheim Venture Fund. New investor Hostplus via the IP Group Hostplus Innovation Fund and LifeSci Capital participated in the round. WHAT IT DOES Brainomix is an...
Healthcare providers performing surgery on a patient with lights shining down from the ceiling
By  Jessica Hagen 05:18 pm October 13, 2023
British medtech company Brainomix and Switzerland-based remote robotic surgical company Nanoflex Robotics announced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to codevelop an AI-assisted magnetic navigation system for stroke-related robotic surgical tools. Innovate UK, the innovation agency in the United Kingdom, and Innosuisse, Switzerland's Innovation Agency,...
Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund
By  Anna Engberg 01:51 am December 23, 2021
The British medtech company Brainomix has announced that it has closed a series B funding round with a total investment of approximately £16 million. The previous investors Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund (OUIF), who are participating again in this round, have been joined by Tencent Holdings. WHY IT MATTERS Brainomix recently took the ...